000			01595 a2200469 4500
005			20250514074759.0
264		0	_c20030926
008			200309s 0 0 eng d
022			_a1096-5645
040			_aNLM _beng _cNLM
100	1		_aStockl, Karen
245	0	0	_aA comparison of costs for four oral antidiabetic regimens within a managed care population. _h[electronic resource]
260			_bManaged care interface _cJul 2003
300			_a31-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aCalifornia
650	0	4	_aCarbamates _xadministration & dosage
650	0	4	_aCohort Studies
650	0	4	_aData Interpretation, Statistical
650	0	4	_aDiabetes Mellitus, Type 2 _xdrug therapy
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGlyburide _xadministration & dosage
650	0	4	_aHealth Care Costs _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xadministration & dosage
650	0	4	_aInsulin _xadministration & dosage
650	0	4	_aInsurance Claim Review
650	0	4	_aMale
650	0	4	_aManaged Care Programs _xeconomics
650	0	4	_aMetformin _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aPiperidines _xadministration & dosage
650	0	4	_aRetrospective Studies
700	1		_aVanderplas, Ann M
700	1		_aNicklasson, Lars
773	0		_tManaged care interface _gvol. 16 _gno. 7 _gp. 31-6
999			_c12682738 _d12682738